×
Lifeward Price to Free Cash Flow Ratio 2014-2024 | LFWD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Lifeward price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
View More
Lifeward Price to Free Cash Flow Ratio 2014-2024 | LFWD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Lifeward price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$236.9B
Intuitive Surgical (ISRG)
$174.1B
Alcon (ALC)
$48.5B
IQVIA Holdings (IQV)
$44.6B
IDEXX Laboratories (IDXX)
$42.6B
Edwards Lifesciences (EW)
$40.5B
DexCom (DXCM)
$28.8B
STERIS (STE)
$23.6B
SONOVA HOLDING (SONVY)
$21B
Waters (WAT)
$20.1B
Hologic (HOLX)
$19.1B
Sysmex ADR (SSMXY)
$12.5B
Fresenius Medical Care AG KGaA (FMS)
$12.2B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.6B
Penumbra (PEN)
$7.8B
Glaukos (GKOS)
$7.1B
Masimo (MASI)
$5.9B
TransMedics (TMDX)
$5.5B
Integer Holdings (ITGR)
$4.4B
PROCEPT BioRobotics (PRCT)
$4.3B
Tandem Diabetes Care (TNDM)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.7B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.5B
Nihon Kohden (NHNKY)
$2.3B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.1B